Li Shi
Impact in
- Immunology top 5%
- Immunotherapy and Immune Responses
- Immune Response and Inflammation
- Infectious Diseases top 5%
- Viral gastroenteritis research and epidemiology
- SARS-CoV-2 and COVID-19 Research
Papers in
- Epidemiology 16
- Hepatitis B Virus Studies 7
- Influenza Virus Research Studies 4
- Cervical Cancer and HPV Research 4
-
- RNA Interference and Gene Delivery 4
- Co-authors
- Gautam Sanyal (3 shared papers)Brian K. Meyer (1 shared paper)Robert D. Sitrin (4 shared papers)Michael J. Caulfield (3 shared papers)Roxana Ionescu (3 shared papers)Craig T. Przysiecki (3 shared papers)John W. Shiver (3 shared papers)David B. Volkin (2 shared papers)
- Journals
- Journal of Pharmaceutical Sciences (4 papers)Human Vaccines & Immunotherapeutics (3 papers)Human Vaccines (2 papers)Vaccine (1 paper)Frontiers in Immunology (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Li Shi
42 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 119
- Immunology 457
- Infectious Diseases 374
- Epidemiology 612
- Pharmaceutical Science 80
- Microbiology 74
Countries citing papers authored by Li Shi
This map shows the geographic impact of Li Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Shi more than expected).
Fields of papers citing papers by Li Shi
This network shows the impact of papers produced by Li Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Shi. The network helps show where Li Shi may publish in the future.
Co-authors
The 25 scholars most cited alongside Li Shi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 275 | |
| 2 | 2020 | 153 | |
| 3 | 2007 | 131 | |
| 4 | 2006 | 106 | |
| 5 | 2007 | 98 | |
| 6 | 2005 | 97 | |
| 7 | 2002 | 81 | |
| 8 | 2007 | 70 | |
| 9 | 2012 | 65 | |
| 10 | 2005 | 62 | |
| 11 | 2006 | 60 | |
| 12 | 2010 | 48 | |
| 13 | 2021 | 43 | |
| 14 | A missense mutation in the gammaD-crystallin gene CRYGD associated with autosomal dominant congenital cataract in a Chinese family. | 2006 | 26 |
| 15 | 2023 | 24 | |
| 16 | 2019 | 23 | |
| 17 | 2009 | 19 | |
| 18 | 2022 | 15 | |
| 19 | 2008 | 7 | |
| 20 | 2022 | 7 |
About Li Shi
Li Shi is a scholar working on Epidemiology, Molecular Biology, Immunology, Mechanics of Materials and Infectious Diseases, having authored 43 papers that have together received 1.5k indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (7 papers), Immunotherapy and Immune Responses (5 papers), Brake Systems and Friction Analysis (4 papers), RNA Interference and Gene Delivery (4 papers), Influenza Virus Research Studies (4 papers), Cervical Cancer and HPV Research (4 papers), Railway Engineering and Dynamics (4 papers) and Immune Response and Inflammation (3 papers). The work is most often cited by research in Immunology (457 citations), Infectious Diseases (374 citations), Epidemiology (612 citations), Pharmaceutical Science (80 citations) and Microbiology (74 citations). Li Shi has collaborated with scholars based in China and United States. Frequent co-authors include Gautam Sanyal, Brian K. Meyer, Robert D. Sitrin, Michael J. Caulfield, Roxana Ionescu, Craig T. Przysiecki, John W. Shiver, David B. Volkin, Fan Jiang and Xiaoping Liang. Their work appears in journals such as Journal of Pharmaceutical Sciences, Human Vaccines & Immunotherapeutics, Human Vaccines, Vaccine and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.